Point-of-care Capillary Blood Lactate Measurements in Human Immunodeficiency Virus–uninfected Children With In Utero Exposure to Human Immunodeficiency Virus and Antiretroviral Medications
暂无分享,去创建一个
Paige L. Williams | L. Mofenson | P. Williams | J. Read | K. Rich | M. Crain | K. Tassiopoulos | R. Griner | Katherine Tassiopoulos
[1] J. B. Groener,et al. Short communication: decrease in mitochondrial transmembrane potential in peripheral blood mononuclear cells of HIV-uninfected subjects undergoing HIV postexposure prophylaxis. , 2011, AIDS research and human retroviruses.
[2] Paige L. Williams,et al. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. , 2011, AIDS patient care and STDs.
[3] E. Ruiz-Pesini,et al. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. , 2010, Human molecular genetics.
[4] J. Pines,et al. Point-of-care testing at triage decreases time to lactate level in septic patients. , 2010, The Journal of emergency medicine.
[5] S. Sankey,et al. Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. , 2010, The Journal of emergency medicine.
[6] G. Aldrovandi,et al. Antiretroviral Exposure and Lymphocyte mtDNA Content Among Uninfected Infants of HIV-1-Infected Women , 2009, Pediatrics.
[7] J. Bakker,et al. Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: A retrospective observational study* , 2009, Critical care medicine.
[8] J. Micheli,et al. Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment , 1998, Intensive Care Medicine.
[9] S. Reynolds,et al. Validation of a portable hand-held lactate analyzer for determination of blood lactate in patients on antiretroviral therapy in Uganda. , 2008, Journal of acquired immune deficiency syndromes.
[10] B. Karon,et al. Comparison and validation of point of care lactate meters as a replacement for fetal pH measurement. , 2008, Clinical biochemistry.
[11] M. Cocchi,et al. Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] T. Esterhuizen,et al. Validation of the Accutrend lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[13] M. Koenig. Presentation and diagnosis of mitochondrial disorders in children. , 2008, Pediatric neurology.
[14] Marni J. Falk,et al. Mitochondrial Disease: A Practical Approach for Primary Care Physicians , 2007, Pediatrics.
[15] J. Lundgren,et al. Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy , 2007, AIDS.
[16] A. Karstaedt,et al. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] J. Blangero,et al. Genetic determinants of mitochondrial content. , 2007, Human molecular genetics.
[18] P. Rustin,et al. Clinical mitochondrial dysfunction in uninfected children born to HIV‐infected mothers following perinatal exposure to nucleoside analogues , 2007, Environmental and molecular mutagenesis.
[19] F. Dela,et al. Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAART. , 2007, The Journal of infection.
[20] M. Falagas,et al. Hyperlactatemia due to nevirapine. , 2006, Annals of internal medicine.
[21] F. Dabis,et al. Serum Lactate Levels in Infants Exposed Peripartum to Antiretroviral Agents to Prevent Mother-to-Child Transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 Study, Abidjan, Ivory Coast , 2006, Pediatrics.
[22] J. Mukherjee,et al. Point of care testing for antiretroviral therapy-related lactic acidosis in resource-poor settings , 2006, AIDS.
[23] D. A. Weinstein,et al. Clinical evaluation of a portable lactate meter in type I glycogen storage disease , 2005, Journal of Inherited Metabolic Disease.
[24] T. Bourgeron,et al. Clinical presentation of mitochondrial disorders in childhood , 1996, Journal of Inherited Metabolic Disease.
[25] G. McComsey,et al. Mitochondrial Dysfunction: Patient Monitoring and Toxicity Management , 2004, Journal of acquired immune deficiency syndromes.
[26] M. Gerschenson,et al. Mitochondrial dysfunction in AIDS and its treatment. , 2004, Mitochondrion.
[27] T. File,et al. Lack of Recurrence of Hyperlactatemia in HIV-Infected Patients Switched From Stavudine to Abacavir or Zidovudine , 2004, Journal of acquired immune deficiency syndromes.
[28] M. de Górgolas,et al. Drug points: Fatal lactic acidosis associated with tenofovir , 2003, BMJ : British Medical Journal.
[29] D. Money,et al. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy , 2003, The Pediatric infectious disease journal.
[30] R. Artuch,et al. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment , 2003, The Pediatric infectious disease journal.
[31] B. Yip,et al. Mitochondrial Toxicity in the Era of HAART: Evaluating Venous Lactate and Peripheral Blood Mitochondrial DNA in HIV-Infected Patients Taking Antiretroviral Therapy , 2003, Journal of acquired immune deficiency syndromes.
[32] A. Carr. Lactic acidemia in infection with human immunodeficiency virus. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] J. Gerstoft,et al. Natural History of Hyperlactataemia in Human Immunodeficiency Virus-1-infected Patients During Highly Active Antiretroviral Therapy , 2003, Scandinavian journal of infectious diseases.
[34] B. Gazzard,et al. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors , 2002, AIDS.
[35] C. Giaquinto,et al. Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission. , 2001, AIDS.
[36] T. Kakuda,et al. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy? , 2000, Current opinion in infectious diseases.
[37] P. Rustin,et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues , 1999, The Lancet.
[38] S. Gortmaker,et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. , 1999, JAMA.
[39] J. Smeitink,et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway , 1998, AIDS.